Print

Neurosearch A/S (NEUR.CO) Closes the Sale of Huntexil® to Teva Pharmaceutical Industries Limited (TEVA) and Adjusts the Expectations to the Full-Year Result  
10/25/2012 9:40:28 AM

Today, NeuroSearch A/S (OMX: NEUR) closed the asset transfer agreement with Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) concerning the sale of the Huntexil® project to Teva as described in announcement no. 21-12 of 27 September 2012. The agreement was approved by NeuroSearch shareholders at the Extraordinary General Meeting, which was held on 23 October 2012.
//-->